Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

European Institute of Oncology

Status: Enrolling

Conditions: Lung Cancer (Diagnosis); NSCLC

Study type: Observational

Funder types: Other

Identifiers

NCT07325864

UID 4058

IEO 1956 (Other Identifier)

Details and patient eligibility

About

investigate the molecular differences between primitive lung cancer and the metastatic site.

Enrollment: 25 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients aged ≥18 years fit enough to tolerate the surgical operation;
• the operative risk is considered low based on respiratory reserve and cardiac assessment;
• the patient has clearly expressed willingness to adhere;
• availability of pathological material for tumor DNA extraction and NGS execution.

Exclusion criteria

• Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study.
• Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation.
• Recent or ongoing severe or clinically significant infection.

Trial design

25 participants in 1 patient group

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site in patient diagnosed with NSCLC

Description:

To investigate the molecular differences between primitive lung cancer and the metastatic site.